Research ArticleOriginal Research

Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature

Chyke A. Doubeni, Christopher D. Jensen, Stacey A. Fedewa, Virginia P. Quinn, Ann G. Zauber, Joanne E. Schottinger, Douglas A. Corley and Theodore R. Levin
The Journal of the American Board of Family Medicine November 2016, 29 (6) 672-681; DOI: https://doi.org/10.3122/jabfm.2016.06.160060

References

  1. 1.↵
    1. Siegel R,
    2. Naishadham D,
    3. Jemal A
    . Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Ferlay J,
    2. Shin HR,
    3. Bray F,
    4. Forman D,
    5. Mathers C,
    6. Parkin DM
    . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. von Karsa L,
    2. Patnick J,
    3. Segnan N,
    4. et al
    . European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication. Endoscopy 2013;45:51–9.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627–37.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Leddin DJ,
    2. Enns R,
    3. Hilsden R,
    4. et al
    . Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol 2010;24:705–14.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Zauber AG,
    2. Lansdorp-Vogelaar I,
    3. Knudsen AB,
    4. Wilschut J,
    5. van Ballegooijen M,
    6. Kuntz KM
    . Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:659–69.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Allison JE,
    2. Sakoda LC,
    3. Levin TR,
    4. et al
    . Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 2007;99:1462–70.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    National Colorectal Cancer Roundtable. National Colorectal Cancer Roundtable. 2016. Available from: http://nccrt.org/about/.
  9. 9.↵
    1. Levin TR,
    2. Jamieson L,
    3. Burley DA,
    4. Reyes J,
    5. Oehrli M,
    6. Caldwell C
    . Organized colorectal cancer screening in integrated health care systems. Epidemiologic Reviews 2011;33:101–10.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Benson VS,
    2. Patnick J,
    3. Davies AK,
    4. et al
    . Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Canc 2008;122:1357–67.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Gupta S,
    2. Sussman DA,
    3. Doubeni CA,
    4. et al
    . Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst 2014;106:dju032.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Grazzini G,
    2. Ventura L,
    3. Zappa M,
    4. et al
    . Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: Observational study from the Florence district. Gut 2010;59:1511–5.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Cha JM,
    2. Lee JI,
    3. Joo KR,
    4. et al
    . Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system. Dig Dis Sci 2012;57:2178–83.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Doubeni CA,
    2. Field TS,
    3. Buist DS,
    4. et al
    . Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 2007;109:612–20.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Mandel JS,
    2. Bond JH,
    3. Church TR,
    4. et al
    . Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365–71.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Kronborg O,
    2. Jørgensen OD,
    3. Fenger C,
    4. Rasmussen M
    . Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol 2004;39:846–51.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Hardcastle JD,
    2. Chamberlain JO,
    3. Robinson MH,
    4. et al
    . Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. van Rossum LG,
    2. van Rijn AF,
    3. Laheij RJ,
    4. et al
    . Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82–90.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Cole SR,
    2. Young GP,
    3. Esterman A,
    4. Cadd B,
    5. Morcom J
    . A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117–22.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Morikawa T,
    2. Kato J,
    3. Yamaji Y,
    4. Wada R,
    5. Mitsushima T,
    6. Shiratori Y
    . A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422–8.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Dancourt V,
    2. Hamza S,
    3. Manfredi S,
    4. et al
    . Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening. Eur J Cancer Prev 2016;25:109–14.
    OpenUrl
  22. 22.↵
    1. van Rossum LG,
    2. van Rijn AF,
    3. van Oijen MG,
    4. et al
    . False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009;125:746–50.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Digby J,
    2. Fraser CG,
    3. Carey FA,
    4. et al
    . Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol 2013;66:415–9.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. McDonald PJ,
    2. Digby J,
    3. Innes C,
    4. et al
    . Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis 2013;15:e151–e159.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. van Roon AH,
    2. Hol L,
    3. van Vuuren AJ,
    4. et al
    . Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol 2012;107:99–107.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords